In the cardiovascular system, IGFBP-7 has been linked to myocardial fibrosis, endothelial dysfunction, and PAH (Ko et al., 2022; Aboumsallem and de Boer, 2024; Katoh et al., 2024). Here, IGFBP7 is linked to endothelial dysfunction.